IMMULOGIC Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMMULOGIC

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul Getman who wrote (31)	5/6/1996 2:26:00 PM
From: Lyle Abramowitz	of 305

Paul, thanks for your informative and insightful reply. I was looking for some assurance that things are O.K with IMUL and your post provided that. As I recall, a similar situation obtained with the Phase II data, where the results were positive but the stock went down due to some concerns about the results as compared to the placebo group. At that time, I received my re-assurance by calling the company. I spoke to the CFO (who was very friendly, and didn't mind taking time for a small investor) who said that IMUL was "doing nothing differently going forward" as a consequence of the Phase II outcome. I.e, IMUL was satisfied with the efficacy of the therapy, and was continuing to develop the treatments for ragweed and other allergies. The stock eventually recovered and made new highs and should do so again now. Regards, Lyle

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next